Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adoptive Cellular Therapy”

437 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 437 results

Early research (Phase 1)Looking for participantsNCT06926894
What this trial is testing

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Who this might be right for
Epstein-Barr VirusCytomegalovirus InfectionsAdenovirus+2 more
Monica Bhatia 18
Not applicableStudy completedNCT05713513
What this trial is testing

Manufacture of Clinical T-cell Products for Future Treatment

Who this might be right for
Virus-specific T Cells
University Hospital, Basel, Switzerland 9
Early research (Phase 1)Study completedNCT03441100
What this trial is testing

TCR-engineered T Cells in Solid Tumors: IMA202-101

Who this might be right for
Solid Tumor, AdultRefractory CancerRecurrent Cancer+1 more
Immatics US, Inc. 16
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT05107739
What this trial is testing

DeTIL-0255 in Adults With Advanced Malignancies

Who this might be right for
Platinum-resistant Ovarian CancerEndometrial CancerCervical Cancer
Nurix Therapeutics, Inc. 5
Early research (Phase 1)Not Yet RecruitingNCT06358053
What this trial is testing

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers

Who this might be right for
Cervical CancerAnal CancerHead and Neck Cancers+1 more
Corregene Biotechnology Co., Ltd 24
Early research (Phase 1)Active Not RecruitingNCT05768347
What this trial is testing

Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC

Who this might be right for
Urothelial CarcinomaNon-Invasive Bladder Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 9
Very early researchUnknownNCT03910842
What this trial is testing

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Who this might be right for
Non-Hodgkin Lymphoma of IntestineLeukemia
Timmune Biotech Inc. 12
Early research (Phase 1)Study completedNCT00182650
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
City of Hope Medical Center 5
Testing effectiveness (Phase 2)WithdrawnNCT00159055
What this trial is testing

Adoptive Immunotherapy for CMV Disease

Who this might be right for
CMV Disease
Hadassah Medical Organization 20
Testing effectiveness (Phase 2)Looking for participantsNCT07627711
What this trial is testing

Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally AdvancedMetastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Ended earlyNCT05100316
What this trial is testing

Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials

Who this might be right for
Neoplasms
GlaxoSmithKline 16
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Early research (Phase 1)Study completedNCT00900809
What this trial is testing

QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
ImmunityBio, Inc. 7
Early research (Phase 1)Study completedNCT02215967
What this trial is testing

Study of T Cells Targeting B-Cell Maturation Antigen for Previously Treated Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-Multiple
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05981001
What this trial is testing

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 170
Testing effectiveness (Phase 2)Study completedNCT03296137
What this trial is testing

Adoptive Cell Therapy Across Cancer Diagnoses

Who this might be right for
Cancer
Inge Marie Svane 25
Testing effectiveness (Phase 2)WithdrawnNCT05628545
What this trial is testing

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

Who this might be right for
Advanced Hepatocellular Carcinoma
Guangdong GD Kongming Biotech LLC
Early research (Phase 1)UnknownNCT03258359
What this trial is testing

Personalized Adoptive Cellular Therapy Targeting MDS Stem Cell Neoantigens (PACTN)

Who this might be right for
Myelodysplastic Syndromes
PersImmune, Inc 12
Early research (Phase 1)Looking for participantsNCT06612645
What this trial is testing

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Who this might be right for
Pediatric CancersSolid Tumor Pediatric
Chulalongkorn University 9
Next Page